Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Transgene Biotek Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Transgene Biotek Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Transgene SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Transgene SA Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Transgenomic Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Transgenomic Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Transition Therapeutics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Transition Therapeutics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Trimeris Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Trimeris Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Trinity Medical Group USA Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Trinity Medical Group USA Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

TrioBiotics Pharma AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

TrioBiotics Pharma AG Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Triochem Products Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Triochem Products Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Trius Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Trius Therapeutics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

TrovaGene, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

TrovaGene, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

LegacyXChange, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

LegacyXChange, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

TrueYou.com, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

TrueYou.com, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tsumura & Co. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tsumura & Co. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

TTK Healthcare Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

TTK Healthcare Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Twilight Litaka Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Twilight Litaka Pharmaceuticals Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tyche Industries Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tyche Industries Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Contango Asset Management Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Contango Asset Management Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tyson Bioresearch Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tyson Bioresearch Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

UCB SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

UCB SA Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ULURU Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ULURU Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Unichem Laboratories Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Unichem Laboratories Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Unigene Laboratories Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Unigene Laboratories Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Unipharm AD Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Unipharm AD Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Unisplendour Guhan Group Co Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Unisplendour Guhan Group Co Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

United Gene High-Tech Group Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

United Gene High-Tech Group Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

United Therapeutics Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

United Therapeutics Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

University Health Industries, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

University Health Industries, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Unjha Formulations Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Unjha Formulations Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Upstream Biosciences, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Upstream Biosciences, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Urigen Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Urigen Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

US BioTec, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

US BioTec, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Valeant Pharmaceuticals International, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Valeant Pharmaceuticals International, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ValiRX PLC. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ValiRX PLC. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Vanda Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vanda Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Vardhaman Laboratories Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vardhaman Laboratories Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Vectura Group plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vectura Group plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Velcera Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Velcera Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Venkat Pharma Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Venkat Pharma Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Venmax Drugs And Pharmaceuticals Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Venmax Drugs And Pharmaceuticals Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ventana Biotech, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ventana Biotech, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Venturepharm Laboratories Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Venturepharm Laboratories Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Venus Remedies Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Venus Remedies Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Vernalis plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vernalis plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Verona Pharma plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Verona Pharma plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Veropharm Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Veropharm Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Vertex Pharmaceuticals Incorporated Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vertex Pharmaceuticals Incorporated Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Vertical Health Solutions Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vertical Health Solutions Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Vetoquinol SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vetoquinol SA Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

VIA Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

VIA Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Vical Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vical Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1